Dubai, UAE, 24 July, 2012: Abraaj Capital, a leading private equity manager investing in global growth markets, today announced the completion of the acquisition of Aureos Capital (“Aureos”), a private equity fund management group investing in small and mid-cap companies (“SMC”) in Asia, Africa and Latin America.
With the consummation of this acquisition, Abraaj Capital now has approximately US$ 7.5 billion in assets under management, a presence in over 30 countries, and over 150 investments managed by a seasoned team of investment professionals with unmatched local expertise.
Announcing the completion of the transaction, Arif Naqvi, Founder and Group Chief Executive, Abraaj Capital said, “The acquisition of Aureos is a pivotal moment for Abraaj as it consolidates our position as the pre-eminent private equity fund manager in global growth markets. As a result, Abraaj is able to provide investors with a unique opportunity to invest in high growth markets through multiple platforms”.
“The acquisition is a significant step in executing the vision we set ourselves just over a decade ago of creating a dedicated global growth markets private equity firm. We share a common philosophy with Aureos, combining a track record of strong investor returns with an appreciation of the long-term social and economic benefits that our model of investing in growth markets can deliver”, Mr. Naqvi added.
Sev Vettivetpillai, Executive Chairman, Aureos said, “We are delighted to have completed this transaction with Abraaj which sets the strategic path for Aureos’ long-term growth and allows us to deliver value to our investors by bringing our portfolio of partner companies into new markets and developing mutually beneficial relationships with the Abraaj portfolio. From the outset, it has been clear that the business models, working cultures, and operational footprint of our two businesses fit together extremely well.”
While Aureos and Abraaj’s Riyada Enterprise Development (RED) Funds will benefit from the synergies of being part of a common platform, and operate under the single brand ‘Aureos’, all Aureos and RED Funds will continue according to their existing Fund mandates and investment guidelines.
Tom Speechley, Senior Partner at Abraaj Capital, has been appointed Chief Executive Officer of Aureos Capital with overall responsibility for the firm’s SMC assets under management of c. US$ 1.75 billion. Mr. Vettivetpillai assumes the position of Executive Chairman of Aureos Capital and joins the Executive Committee of Abraaj Capital. The completed transaction has been strongly supported by Aureos’ core investors, including CDC, the UK’s development finance institution.
When Dubai-based Abraaj Group bought Advent International's controlling stake in CARE Hospitals, it was a deal that had been a long time coming."I remember going there almost two years ago and saying to the doctors, ‘We would love to work with you,'" remembers Khawar Mann, managing director and head of healthcare at Abraaj. "Advent then started an auction process, but we knew the business well before that process started." more >
Rather than a challenge, Dubai’s Abraaj Group views population growth across the region as an opportunity for private equity investors.Founded in 2002, Abraaj was the pioneer of private equity in the Middle East and emerging markets across the globe. It is the most important private equity player in Africa, Asia, Latin America and the Middle East, having built up a portfolio worth about $9bn across 30 countries. more >
The Abraaj Group, a leading investor operating in global growth markets, today announced the acquisition, through its second generation North Africa Fund (‘ANAF II’), of a stake in Société d’Articles Hygiéniques (‘SAH’ or the ‘Company’), a leading producer of disposable household and personal care products for babies, women and adults in Tunisia. Abraaj acquired a 49% stake in JM Holding, the company that holds a majority share in SAH. SAH is listed on the Tunisian Stock Exchange. more >
The Abraaj Group (“Abraaj” or the “Group”), a leading investor operating in global growth markets, announced that it completed the sale of its entire stake in Integrated Diagnostics Holdings (“IDH” or the “Company”) on November 2015, through its affiliate Integrated Diagnostics Group Limited (“IDG”). The Abraaj Group had invested in IDH through one of its Funds. more >
The Abraaj Group (‘Abraaj’ or the ‘Group’), a leading investor operating in global growth markets, today announced that it has agreed to acquire, through one of its Funds, a majority stake in Quality CARE India Limited (‘CARE’ or ‘the Company’), one of the largest multi-specialty healthcare providers in India, from global private equity firm Advent International. more >